A Phase I/II Open Label Study of IV Busulfan (Busulfex) in Multiple Myeloma Patients 65 Years of Age or Older, or With Renal Insufficiency Undergoing Autologous Transplantation.

Trial Profile

A Phase I/II Open Label Study of IV Busulfan (Busulfex) in Multiple Myeloma Patients 65 Years of Age or Older, or With Renal Insufficiency Undergoing Autologous Transplantation.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 26 May 2017

At a glance

  • Drugs Busulfan (Primary)
  • Indications Multiple myeloma
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Feb 2012 Actual patient number (13) added as reported by ClinicalTrials.gov.
    • 27 Feb 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 12 Aug 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top